Please assess the completion status of the following clinical trial:

Trial Title: The Feasibility of Florbetapir Quantitation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Readers have undergone Amyvid reader training~* Readers have minimal experience with quantitation of amyloid PET scans~Exclusion Criteria:~* Readers have previously been trained to quantitate amyloid PET scans

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Physician Readers (Type: EXPERIMENTAL): Physician readers will interpret Amyvid scans using qualitative analysis followed by the use of quantitation. No subjects will be exposed to Florbetapir F 18 as part of this study.

Based on this trial design, predict the completion outcome and termination type (if applicable).